Shenjie Yang

Targeted agents combined with immune checkpoint inhibitors in advanced non-small cell lung cancer: a systematic review and externally anchored Bayesian network meta-analysis

Targeted agents combined with PD-1 or PD-L1 blockade have been investigated in advanced non-small cell lung cancer (NSCLC), but the evidence is dominated by small single-arm studies in clinically distinct populations. We evaluated class-level activity, safety, and progression-fre...